Attached files

file filename
8-K - FORM 8-K - ULTRALIFE CORPf8k_021314.htm
Exhibit 99.1
 
Company Contact:  Investor Relations Contact:
Ultralife Corporation
Philip A. Fain
(315) 332-7100
pfain@ulbi.com
LHA
Jody Burfening
(212) 838-3777
jburfening@lhai.com
 
                                                                                                                                                                                                    
Ultralife Corporation Reports Fourth Quarter Results


NEWARK, N.Y. – February 13, 2014 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income from continuing operations of $0.2 million on revenue of $20.2 million for the quarter ended December 31, 2013.  For the fourth quarter of 2012, the company reported operating income from continuing operations of $2.4 million on revenue of $29.3 million.

“The fourth quarter closed a year during which the slowdown in global defense-related spending and decision-making dominated our top line comparables.   During 2013, we right-sized the business model and stabilized quarterly revenues for our Battery & Energy Products business which compensated for weak Communication Systems’ sales such that we delivered a modest operating loss for the year, in line with our guidance,” said Michael D. Popielec.

“As we enter 2014, we are starting to realize initial returns on the investments we made in new product development over the past two years, particularly in the areas of portable power, medical carts and integrated communications systems.   With the maturation of our new products, we expect to gain further customer acceptance during the year and generate top-line growth.     This growth, along with deeply-rooted productivity gains and improved liquidity, will enable us to fully leverage our highly-efficient business model,” concluded Popielec.


Fourth Quarter 2013 Financial Results

Revenue was $20.2 million, compared to $29.3 million for the fourth quarter of 2012, a 31% decline.     Battery & Energy Products sales were $15.9 million, compared to $18.8 million last year, a 16% decline, reflecting last year’s fulfillment of a large order to an allied country’s department of defense and the slowdown in the government and defense order rate for rechargeable and non-rechargeable batteries.  Communications Systems sales were $4.3 million, compared to $10.4 million for the same period last year, a decrease of $6.1 million.  Prior year Communications Systems’ sales benefited from the fulfillment of several large orders for amplifiers from international defense customers.

Gross profit was $5.6 million, or 27.7% of revenue, compared to $9.5 million, or 32.3% of revenue, for the same quarter a year ago, a decrease of 460 basis points, primarily attributable to a lower mix of Communication Systems sales.  Battery & Energy Products’ gross margin was 26.1%, compared to 27.0% last year, a 90 basis point decrease reflecting lower sales volume and a less favorable product mix.   Communications Systems’ gross margin was 33.5%, compared to 41.9% last year, a decrease of 840 basis points also reflecting the impact of lower sales volume on production and the product mix.

 
 

 
Operating expenses declined $1.7 million, or 24%, to $5.4 million, compared to $7.1 million a year ago, primarily due to reductions in general and administrative expense and continued focus on controlling discretionary spending.  As a percent of revenue, operating expenses were 26.6%, compared to 24.3% a year ago.

Operating profit was $0.2 million, compared to $2.4 million for the same period in 2012, reflecting lower gross profit offset by operating expense reductions. Operating margin was 1.1%, compared to 8.0% for the year-earlier period.

Net income from continuing operations was $0.1 million, or $0.01 per share, compared to net income of $2.1 million, or $0.12 per share, for the fourth quarter of 2012.

Outlook

For 2014, management expects mid-single digit organic revenue growth, despite continued constraints on global government spending.  Based on this outlook for revenue growth and the improvements made to the business model in 2013, management expects to increase operating profit for the year and generate a mid-single digit operating margin.

Management cautions that the timing of orders and shipments may cause variability in quarterly results.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from portable power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: uncertain global economic conditions, increased competitive environment and pricing pressures, disruptions related to restructuring actions and delays. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 
 

 
Conference Call Information

Ultralife will hold its fourth quarter earnings conference call today at 10:00 AM ET. To participate, please call (800) 915-4836, identify yourself and ask for the Ultralife call. The conference call will also be broadcast live over the Internet at http://investor.ultralifecorporation.com. To listen to the call, please go to the web site at least fifteen minutes early to download and install any necessary audio software. For those who cannot listen to the live webcast, a replay of the webcast will be available shortly after the call at the same location.
 
 

 
 
 

 
ULTRALIFE CORPORATION
CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Per Share Amounts)
(unaudited)
             
             
   
December 31,
   
December 31,
 
ASSETS
 
2013
   
2012
 
             
Current assets:
           
   Cash and cash equivalents
  $ 16,489     $ 10,078  
   Trade accounts receivable, net
    14,238       20,913  
   Inventories
    26,053       30,370  
   Prepaid expenses and other current assets
    2,031       2,461  
     Total current assets
    58,811       63,822  
                 
Property and equipment
    10,202       12,415  
                 
Other assets:
               
   Goodwill, intangible and other assets
    21,203       21,481  
                 
Total Assets
  $ 90,216     $ 97,718  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
                 
Current liabilities:
               
   Short-term debt and current portion of long-term debt
  $ -     $ -  
   Accounts payable
    7,053       11,357  
   Other current liabilities
    4,971       8,535  
      Total current liabilities
    12,024       19,892  
                 
Long-term liabilities:
               
    Other long-term liabilities
    4,547       4,370  
                 
Shareholders' equity:
               
  Ultralife equity:
               
    Common stock, par value $0.10 per share
    1,888       1,886  
    Capital in excess of par value
    174,932       173,791  
    Accumulated other comprehensive loss
    (614 )     (620 )
    Accumulated deficit
    (94,804 )     (93,878 )
 
    81,402       81,179  
    Less -- Treasury stock, at cost
    7,658       7,658  
      Total Ultralife equity
    73,744       73,521  
  Noncontrolling interest
    (99 )     (65 )
      Total shareholders' equity
    73,645       73,456  
                 
Total Liabilities and Shareholders' Equity
  $ 90,216     $ 97,718  
                 
 
 
 
 

 
ULTRALIFE CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In Thousands, Except Per Share Amounts)
(Unaudited)
                         
                         
   
Three Month Periods Ended
   
Twelve Month Periods Ended
 
                         
   
December 31,
   
December 31,
   
December 31,
   
December 31,
 
   
2013
   
2012
   
2013
   
2012
 
                         
Revenues:
                       
  Battery & energy products
  $ 15,861     $ 18,846     $ 57,077     $ 71,084  
  Communications systems
    4,315       10,423       21,758       30,573  
Total revenues
    20,176       29,269       78,835       101,657  
                                 
Cost of products sold:
                               
  Battery & energy products
    11,714       13,760       42,739       53,522  
  Communications systems
    2,869       6,058       13,475       19,405  
Total cost of products sold
    14,583       19,818       56,214       72,927  
                                 
Gross profit
    5,593       9,451       22,621       28,730  
                                 
Operating expenses:
                               
  Research and development
    1,403       1,511       5,859       7,216  
  Selling, general, and administrative
    3,967       5,587       17,386       21,628  
Total operating expenses
    5,370       7,098       23,245       28,844  
                                 
Operating income (loss)
    223       2,353       (624 )     (114 )
                                 
Other income (expense):
                               
  Interest income
    12       -       39       4  
  Interest expense
    (39 )     (124 )     (238 )     (440 )
  Miscellaneous
    5       (41 )     (26 )     (24 )
Income (loss) from continuing operations before income taxes
    201       2,188       (849 )     (574 )
 
                               
Income tax provision - current
    52       152       94       539  
Income tax provision  (benefit) -deferred
    52       (35 )     145       15  
  Total income taxes
    104       117       239       554  
                                 
Net income (loss) from continuing operations
    97       2,071       (1,088 )     (1,128 )
                                 
Discontinued operations:
                               
  Income (loss) from discontinued operations, net of tax
    (31 )     (680 )     128       (501 )
                                 
Net income (loss)
    66       1,391       (960 )     (1,629 )
                                 
Net loss attributable to noncontrolling interest
    3       -       34       31  
                                 
Net income (loss) attributable to Ultralife
  $ 69     $ 1,391     $ (926 )   $ (1,598 )
                                 
Other comprehensive income (loss):
                               
  Foreign currency translation adjustments
    (47 )     446       6       365  
                                 
Comprehensive income (loss) loss attributable to Ultralife
  $ 22     $ 1,837     $ (920 )   $ (1,233 )
                                 
                                 
Net income (loss) attributable to Ultralife common shareholders - basic
                         
  Continuing operations
  $ 0.01     $ 0.12     $ (0.06 )   $ (0.06 )
  Discontinued operations
  $ 0.00     $ (0.04 )   $ 0.01     $ (0.03 )
  Total
  $ 0.00     $ 0.08     $ (0.05 )   $ (0.09 )
Net income (loss) attributable to Ultralife common shareholders - diluted
                         
  Continuing operations
  $ 0.01     $ 0.12     $ (0.06 )   $ (0.06 )
  Discontinued operations
  $ 0.00     $ (0.04 )   $ 0.01     $ (0.03 )
  Total
  $ 0.00     $ 0.08     $ (0.05 )   $ (0.09 )
                                 
                                 
Weighted average shares outstanding - basic
    17,477       17,443       17,465       17,403  
Weighted average shares outstanding - diluted
    17,572       17,443       17,465       17,403